KR101736521B1 - 퀴나졸린 화합물 - Google Patents

퀴나졸린 화합물 Download PDF

Info

Publication number
KR101736521B1
KR101736521B1 KR1020127014231A KR20127014231A KR101736521B1 KR 101736521 B1 KR101736521 B1 KR 101736521B1 KR 1020127014231 A KR1020127014231 A KR 1020127014231A KR 20127014231 A KR20127014231 A KR 20127014231A KR 101736521 B1 KR101736521 B1 KR 101736521B1
Authority
KR
South Korea
Prior art keywords
amino
methyl
benzenesulfonamide
quinazolinyl
methyloxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020127014231A
Other languages
English (en)
Korean (ko)
Other versions
KR20120112441A (ko
Inventor
라라 에스. 칼랜더
브라이언 그리핀 로혼
조앤 필립
Original Assignee
글락소스미스클라인 엘엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 글락소스미스클라인 엘엘씨 filed Critical 글락소스미스클라인 엘엘씨
Publication of KR20120112441A publication Critical patent/KR20120112441A/ko
Application granted granted Critical
Publication of KR101736521B1 publication Critical patent/KR101736521B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1020127014231A 2009-11-03 2010-11-01 퀴나졸린 화합물 Expired - Fee Related KR101736521B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25764609P 2009-11-03 2009-11-03
US61/257,646 2009-11-03
PCT/US2010/054927 WO2011056740A1 (en) 2009-11-03 2010-11-01 Quinazoline compounds

Publications (2)

Publication Number Publication Date
KR20120112441A KR20120112441A (ko) 2012-10-11
KR101736521B1 true KR101736521B1 (ko) 2017-05-16

Family

ID=43970282

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020127014231A Expired - Fee Related KR101736521B1 (ko) 2009-11-03 2010-11-01 퀴나졸린 화합물

Country Status (13)

Country Link
US (1) US8859571B2 (cg-RX-API-DMAC7.html)
EP (1) EP2501233B1 (cg-RX-API-DMAC7.html)
JP (1) JP5836963B2 (cg-RX-API-DMAC7.html)
KR (1) KR101736521B1 (cg-RX-API-DMAC7.html)
CN (1) CN102711474B (cg-RX-API-DMAC7.html)
AU (1) AU2010315361B2 (cg-RX-API-DMAC7.html)
BR (1) BR112012010524A2 (cg-RX-API-DMAC7.html)
CA (1) CA2779989A1 (cg-RX-API-DMAC7.html)
EA (1) EA021439B1 (cg-RX-API-DMAC7.html)
ES (1) ES2523465T3 (cg-RX-API-DMAC7.html)
IL (1) IL219504A (cg-RX-API-DMAC7.html)
MX (1) MX2012005155A (cg-RX-API-DMAC7.html)
WO (1) WO2011056740A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2398797B1 (en) * 2009-02-17 2013-11-06 Boehringer Ingelheim International GmbH Pyrimido[5,4-d]pyrimidine derivatives for the inhibition of tyrosine kinases
CN103159685A (zh) * 2013-04-11 2013-06-19 苏州立新制药有限公司 4-氯-6,7-二(2-甲氧基乙氧基)喹唑啉的制备方法
AU2014353006B2 (en) * 2013-11-20 2019-04-04 Signalchem Life Sciences Corp. Quinazoline derivatives as TAM family kinase inhibitors
WO2015099916A1 (en) 2013-12-26 2015-07-02 Exxonmobil Research And Engineering Company Synthesis of zsm-48 crystals
KR20240017986A (ko) * 2017-09-26 2024-02-08 더 리전트 오브 더 유니버시티 오브 캘리포니아 암 치료를 위한 조성물 및 방법
EP4031247A1 (en) 2019-09-16 2022-07-27 Novartis AG Bifunctional degraders and their methods of use
CA3233057A1 (en) 2021-09-23 2023-03-30 Erasca, Inc. Egfr inhibitor polymorph forms

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070259904A1 (en) 2005-11-01 2007-11-08 Targegen, Inc. Bi-aryl meta-pyrimidine inhibitors of kinases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9508565D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quiazoline derivative
EP2210607B1 (en) * 2003-09-26 2011-08-17 Exelixis Inc. N-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]quinolin-4-yl}oxy)phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide for the treatment of cancer

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070259904A1 (en) 2005-11-01 2007-11-08 Targegen, Inc. Bi-aryl meta-pyrimidine inhibitors of kinases

Also Published As

Publication number Publication date
ES2523465T3 (es) 2014-11-26
EA201290243A1 (ru) 2012-12-28
JP2013510155A (ja) 2013-03-21
IL219504A (en) 2016-09-29
CA2779989A1 (en) 2011-05-12
CN102711474B (zh) 2014-09-10
CN102711474A (zh) 2012-10-03
IL219504A0 (en) 2012-06-28
US8859571B2 (en) 2014-10-14
AU2010315361A1 (en) 2012-05-24
WO2011056740A1 (en) 2011-05-12
EP2501233A1 (en) 2012-09-26
JP5836963B2 (ja) 2015-12-24
EP2501233A4 (en) 2013-06-19
KR20120112441A (ko) 2012-10-11
MX2012005155A (es) 2012-08-31
EA021439B1 (ru) 2015-06-30
EP2501233B1 (en) 2014-09-24
AU2010315361B2 (en) 2014-06-12
BR112012010524A2 (pt) 2017-12-12
US20120220588A1 (en) 2012-08-30

Similar Documents

Publication Publication Date Title
RU2649001C1 (ru) Производные 2,4-дизамещенного фенилен-1,5-диамина и их применения, фармацевтические композиции и фармацевтически приемлемые композиции, полученные из них
JP7859684B2 (ja) Egfr突然変異癌の抑制用化合物及びその医薬用途
KR101501299B1 (ko) 신규한 디벤질아민 구조를 갖는 피리미딘 화합물 및 이것을 함유하는 의약
CN103717602B (zh) 激酶抑制剂
JP5836963B2 (ja) キナゾリン化合物
KR20120114355A (ko) 화합물 및 방법
KR20100051814A (ko) Gpr119 g 단백질-커플링된 수용체의 조절 방법 및 선택된 화합물
CN102264707A (zh) 新型双环型杂环化合物
JP2008514643A (ja) 新規ピペリジニルアミノ−チエノ[2,3−d]ピリミジン化合物
JPWO2006043490A1 (ja) 非芳香環縮合ピリミジン誘導体
CA2870062A1 (en) Pyrrolopyrazone inhibitors of tankyrase
JPWO2015022926A1 (ja) 新規な縮合ピリミジン化合物又はその塩
JP6698633B2 (ja) 複素環化合物
JPWO2007114323A1 (ja) アミノピロリジン化合物
WO2011056739A1 (en) Compounds and methods
WO2017126635A1 (ja) 複素環化合物およびその用途
ES2593057B1 (es) Moduladores selectivos de la actividad del receptor GPR55: derivados de cromenopirazol
US20120157482A1 (en) Compounds and methods
EP3554504B1 (en) Substituted pyrazole-pyrimidines, variants thereof, and uses thereof
WO2011088031A1 (en) Compounds and methods
CN113943251B (zh) 双环庚烯基氨基取代的氮杂芳环类化合物及其医药用途
WO2019141096A1 (zh) 取代脲类化合物及其制备方法和用途
AU2014269229A1 (en) Bicyclic derivative containing pyrimidine ring, and preparation method therefor
KR20050073241A (ko) 몰폴린기가 치환된 퀴나졸린 유도체와 이의 제조방법
KR20050110439A (ko) 퀴나졸린 유도체

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20200511

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20200511